Citigroup’s Indivior Pharmaceuticals INDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66M Sell
54,485
-37,562
-41% -$1.24M ﹤0.01% 2792
2025
Q4
$3.3M Buy
92,047
+55,064
+149% +$1.68M ﹤0.01% 2313
2025
Q3
$892K Sell
36,983
-161,378
-81% -$3.38M ﹤0.01% 3229
2025
Q2
$2.95M Buy
198,361
+61,901
+45% +$721K ﹤0.01% 2340
2025
Q1
$1.28M Sell
136,460
-859,865
-86% -$9.04M ﹤0.01% 3071
2024
Q4
$12.8M Buy
996,325
+751,424
+307% +$7.73M 0.01% 1222
2024
Q3
$2.42M Buy
244,901
+20,147
+9% +$236K ﹤0.01% 2495
2024
Q2
$3.52M Sell
224,754
-42,632
-16% -$769K ﹤0.01% 1888
2024
Q1
$5.72M Sell
267,386
-56,075
-17% -$1.05M 0.01% 1612
2023
Q4
$4.89M Buy
323,461
+169,693
+110% +$3.01M 0.01% 1615
2023
Q3
$3.34M Sell
153,768
-59,658
-28% -$1.36M ﹤0.01% 1651
2023
Q2
$4.95M Buy
+213,426
New +$4.89M 0.01% 1493

Other funds holding INDV